Defense Health Agency Contracting Activity - DHACA
DoW Tuberous Sclerosis Complex, Clinical Translational Research Award
DoW Tuberous Sclerosis Complex, Clinical Translational Research Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing August 6, 2026.
Aug 6, 2026
(6d left)Overview
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of…